Pulmonary Nodule clinical trials
9 active trials name this condition. Describe your situation to see which ones you may be eligible for.
- Image Guided VATS vs. VATS Resection
- Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES
- Specimens for Lung Cancer Panel Design
- Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
- Biomarkers for Risk Stratification in Lung Cancer
- SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
- ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening
- Analysis of Lung Cancer Tissue With Spatial Frequency Domain Imaging
- Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Pulmonary Nodule” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.